A Cambridge-based surgical robotics company backed by a series of global investors is pursuing a possible sale of the business for about $4 billion.
CMR Surgical, which recently raised a further $200 million from existing backers after a regulatory breakthrough in the United States, has hired advisers to consider its options.
Founded in 2014, the company is based in Cambridge, where it also has a manufacturing site.
It employs more than 500 people, including about 400 in the UK, and has raised more than $1 billion since it was founded. That included a $600 million round in 2021 — which valued it at $3 billion and was the largest global medtech private funding round — and the most recent funding injection in April.
The business is backed by SoftBank, the Japanese investor; Tencent, the Chinese tech conglomerate; the venture capital arm of GE Health Care; and Cambridge Innovation Capital, which partners with Cambridge University and surrounding clusters to commercialise intellectual property.
Date: 5 June